Our Research
Our interventional cardiologists participated in early studies of almost every new catheter-placed device and therapeutic transcatheter procedure and took part in nearly every major multi-center FDA trial for devices and transcatheter therapies performed in the US over the past 15 years, including:
- Medtronic Melody® and the Edwards LifeSciences (Edwards-Sapien) transcatheter heart valve in the pulmonic position
- Use of covered Cheatham Platinum Stents for treatment of vascular wall injury
- Post-market trial for Amplatzer® septal occluder device and ventricular septal occluder device
We contribute to national registries to enhance patient care by promoting quality improvements and to develop outcome assessment methods for pediatric catheterization. The registries we participate in include:
- National Cardiovascular Data Registry’s IMPACT Registry™ (Improving Pediatric and Adult Congenital Treatment)
- Congenital Cardiac Catheterization Project on Outcomes
- Congenital Cardiovascular Interventional Study Consortium